Emergent Biosolutions Inc. Sets New 1-Year High at $19.14 (EBS)
Emergent Biosolutions (NYSE:EBS) set a new 52-week high during mid-day trading on Monday, StockRatingsNetwork.com reports. The stock traded as high as $19.14 and last traded at $18.88, with a volume of 110,271 shares. The stock had previously closed at $18.85.
Emergent Biosolutions has a one year low of $12.50 and a one year high of $19.14. The stock’s 50-day moving average is $18.08 and its 200-day moving average is $15.73. The company has a market cap of $686.9 million and a price-to-earnings ratio of 27.01.
Emergent Biosolutions (NYSE:EBS) last announced its earnings results on Monday, August 5th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The company had revenue of $82.40 million for the quarter, compared to the consensus estimate of $75.73 million. During the same quarter last year, the company posted $0.21 earnings per share. Emergent Biosolutions’s revenue was up 17.0% compared to the same quarter last year. Analysts expect that Emergent Biosolutions will post $0.77 EPS for the current fiscal year.
Emergent BioSolutions Inc is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.